HIV nPEP* Process Algorithm - DRAFT

Slides:



Advertisements
Similar presentations
Page Up to Reverse  Employee Health  Page Down to Advance  Employee Health 
Advertisements

Needlestick Safety Christine Curtis, RN Pediatric Infectious Diseases.
A Specialty Pharmacy Rx Care Specialty Pharmacy 6300 Commerce Drive, Westland MI (P) (F) (Toll Free)
GUIDELINES FOR HIV POST-EXPOSURE PROPHYLAXIS FOLLOWING SEXUAL ASSAULT
UN Cares PEP Starter Kit Custodians Training MODULE 4: HIV Post-Exposure Prophylaxis Starter Kits.
Summary of ARV prescribing guidelines in London These slides summarise the recommendations by the London HIV Consortium for prescribing antiretrovirals.
Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug-Use or Other Nonoccupational exposure to HIV Gonzalo Bearman MD, MPH Assistant Professor.
HIV Prophylaxis: Following Occupational and Non-Occupational Exposure Nanik (Nayri) Hatsakorzian Pharm.D./MPH candidate 2014 Touro University, College.
Potential role of PEP, PrEP and ART for HIV Prevention among Men who have Sex with Men Frits van Griensven, PhD, MPH Division of HIV/AIDS Prevention US.
BLOOD BORNE PATHOGEN EXPOSURE Management – What you need to know about Needlesticks and Splashes Amy J. Behrman, MD Occupational Medicine Dept of Emergency.
Staff Health Care Committee Recommendations An update for UAA’s APT and Classified Staff Councils November 2009.
Post Exposure Prophylaxis for HIV
New York State Department of Health AIDS Institute June, 2014
DRAFT Actions to take for exposure to bloodborne pathogens (HIV, Hep C) Do you still suspect source HIV positive? No /UNK Submit additional blood sample.
Can we prevent infection after an exposure
Page Up to Reverse  Employee Health  Page Down to Advance  Employee Health 
The Role of Clinical Pharmacists in Outpatient Psychiatric Clinics Mary A. Gutierrez, Pharm.D., BCPP Associate Professor of Clinical Pharmacy University.
Antiretroviral Postexposure Prophylaxis after Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV in the United States Recommendations.
Experience of a NYC hospital with non- occupational post-exposure prophylaxis (nPEP) Antonio Urbina 1, Georgina Osorio 1, Daniel Egan 2, Paul Galatowitsch.
Non-occupational Postexposure Prophylaxis (nPEP) in New York State Emergency Departments Alexander Ende Bruce D. Agins June 6th, 2006.
Management of Rape Victims Martin Donohoe This presentation was last updated in the early 2000s – I recommend consulting more contemporary medical references.
Cohort Study. Objectives To discuss cohort study designs To discuss data from some cohort studies.
HIV post exposure prophylaxis on your medical elective Dr Sarah Barrett Consultant Sexual Health and HIV Medicine Birmingham Heartlands Hospital.
Michael Hughes, MD Assistant Clinical Professor UCR Eisenhower Medical Associates.
Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.
Pharmacist-Managed HIV Pre-Exposure Prophylaxis (PrEP) Clinic: Preliminary Outcomes From an Urban Community Health Clinic Mark T. Sawkin, PharmD, AAHIVP.
HIV: WHAT IS NEW? DR NYA EBAMA, M.D. LOWCOUNTRY INFECTIOUS DISEASES, PA CARETEAM PLUS, INC SEPTEMBER 18, 2015.
HIV post exposure prophylaxis on your medical elective Dr Ria Daly Specialist Trainee GUM/HIV Birmingham Heartlands Hospital (Dr Sarah Barrett)
PreP Adherence Clubs. MSF ART Adherence clubs ART Adherence clubs are long term retention model of care catering for stable ART patients Based on a quick.
Table of Contents.  Legal and Safety Issues Go Go  Prescriptions and Abbreviations Go Go.
Needlesticks & Exposures 600,000 to one million needle-stick injuries happen every year in the United States. 600,000 to one million needle-stick injuries.
Non-Occupational Post Exposure Prophylaxis NPEP Jude Armishaw Victorian NPEP Service The Alfred.
Dr. Doug Masini.  ABC approach: Abstain, Be Faithful, and correct and consistent use of Condoms  Prevention of mother to child transmission (PMTCT)
PrEP Case Consultation
Maternal Toxicity Management
PrEP for HIV Prevention
Adult and Pediatric Dosages Based on Body Surface Area
Diabetic Shoes/Inserts
North Carolina Medicare Part D
TDF-FTC QD + Raltegravir BID TDF-FTC QD + Lopinavir-ritonavir QD
Pharmacokinetics: HIV Drugs
Updated DHHS Adult and Adolescent HIV Treatment Guidelines: Conversation with Dr. Paul Sax Presentation prepared by: Paul Sax, MD and Brian Wood, MD.
Maternal Toxicity Management
Module 4 (a) Getting started on PrEP
Pharmacokinetics: HIV Drugs
Once Daily Etravirine versus Efavirenz in Treatment-Naive SENSE Trial
PHARMACY TECHNICIAN CHAPTER FOURTEEN.
Atazanavir + ritonavir vs. Lopinavir-ritonavir CASTLE Study
POST EXPOSURE PROPHYLAXIS IN HCW
LPV-RTV versus LPV-RTV + ZDV-3TC in Treatment-Naïve MONARK Trial
Calculating Dosage.
Establishing a Pharmacy Managed HCV Service
Do Patients adherent on PrEP exposed to HIV have seroconversion symptoms & falsely reactive HIV tests? Mark Roche1, Elaney Youssef1, Yvonne Gilleece¹,
Treating Hep C with Novel Agents
Pharmacist.
مدیریت مواجهه با HIV ، HBV و HCV
مبارزه با بیماریها دکتر آناهیتا بابک. مبارزه با بیماریها دکتر آناهیتا بابک.
به نام خدا.
PrEP Pre-Exposure Prophylaxis
100 Partners PrEP[5] Efficacy 75% Adherence 81% 80
Phase 3 Treatment Naïve and Treatment Experienced HIV Coinfection
Needlesticks & Exposures
Practical Pharmaceutical Orientation
HIV.
Considering Monitored Dosage Systems?
Pediatric and Adult Dosages Based on Body Weight
Farinaz khan Dept of FCM
HIV Testing- What’s Your Routine?
Bob Holtkamp, Director of Prevention & Outreach
Centers for Disease Control and Prevention guidelines for evaluating the risk of HIV transmission after occupational exposure (PEP, post-exposure prophylaxis).
Presentation transcript:

HIV nPEP* Process Algorithm - DRAFT Apple Pharmacy Closed: Dispense 3 day supply and give 28 day prescription; recommend going to their pharmacy (or Apple) as soon as possible Perform H&P collect baseline labs Apple Pharmacy Open: Send to pharmacy and give prescription for 28 days – confirm receipt of meds before D/C Note Insurance Coverage Confirm patient contact information : Has Insurance Determine need for nPEP medications Refer to Clinical Algorithm on reverse Give patient the nPEP brochure -for any questions, call the immunologist on call No Insurance nPEP Prescribed – fax referral form to Immunology at x4385 Dispense 3 day supply, give 28 day supply prescription, and on faxed referral form to Immunology, clearly note that this patient does not have insurance – tell patient that someone from Immunology will contact them on how to fill it No nPEP and no follow-up needed then nothing further No nPEP but needs Immunology follow-up, fax referral form to Immunology at x4385 *non-occupational post-exposure prophylaxis

Exposure < 72 hours, then assess as Lower Risk vs. Higher Risk nPEP* Clinical Decision Making Algorithm for Significant Potential HIV Exposure - DRAFT Send Baseline Labs Rapid HIV CBC with differential, Hep B surface antigen, Hep B surface antibody, RPR, Hep C antibody, metabolic panel Exposure < 72 hours, then assess as Lower Risk vs. Higher Risk Lower Risk– 2 meds Truvada (emtricitabine and tenofovir) once daily for > 35 kg OR Retrovir (zidovudine) 20 mg/kg/day divided BID (max 300 mg/dose) AND Epivir (lamivudine) 8 mg/kg/day (max 150 mg/dose) Exposure > 72 hours then NO nPEP meds- must follow up in Immunology and/or Child Protection (especially for high risk exposures) for further testing LOW HIGH Higher Risk – 2 meds above PLUS Reyataz (atazanavir) BID: 150 mg/dose (15-25 kg), 200 mg (25-32 kg), 250 mg (32 to 35 kg ) AND Norvir 100 mg OR Kaletra (lopinavir/ritonavir) 20 mg/kg/day divided BID (max 400 mg/dose) High Risk Exposures: Known HIV positive contact, visible trauma and/or secretions, anal penetration, and other factors (call Immunology if assistance is needed) Prevention efficacy is increased by use of 3 drugs, but it also decreases compliance *non-occupational post-exposure prophylaxis